Hospitals must report ‘suspicious’ controlled substance orders to DEA

The Drug Enforcement Administration last week launched a new online database for reporting “suspicious orders” of opioids and other controlled substances, such as orders of unusual size, frequency or that deviate substantially from a normal pattern. Hospitals, pharmacies and others who dispense controlled substances must register to report to the database under the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018. Reporting to SORS Online satisfies the requirement to report such orders to the DEA administrator and special agent in charge of the Division Office of the DEA for the area in which the registrant is located or conducts business. For more information, visit www.deadiversion.usdoj.gov/sors.